- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Tucatinib/tocatinib is an oral tyrosine kinase inhibitor targeting HER2 protein, which is particularly suitable for the treatment of HER2 posit...
The common side effects of Tucatinib include nausea, fatigue, and hand foot syndrome, which require targeted management to alleviate symptoms a...
The contraindications for Tucatinib include patients with severe liver injury and QT interval prolongation, and strict adherence to medication ...
Attention should be paid to the risks of diarrhea, hepatotoxicity, and drug interactions when using Tucatinib. Diarrhea may cause severe dehydr...
The administration of Ponatinib should follow the principle of fasting, and dosage adjustments should be graded according to the severity of ad...
Ponatinib has clear contraindications for patients with severe cardiovascular disease and uncontrolled hypertension, and strict risk assessment...
Pralsetinib is a targeted therapy drug primarily used for non-small cell lung cancer and thyroid cancer with specific gene mutations. The usage...
The management of side effects of Pralsetinib should focus on rash, pancreatitis, and hypertension. The following are specific measures and p...
Diarrhea, fatigue, and hand foot syndrome during treatment with Lenvatinib are common adverse reactions that require targeted preventive measur...
Lenvatinib has clear contraindications in patients with severe liver and kidney dysfunction and pregnant women, and strict adherence to medicat...
